Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 15, 2020 - Issue 8
Submit an article Journal homepage
504
Views
23
CrossRef citations to date
0
Altmetric
Review

Novel approaches and current challenges with targeting the endocannabinoid system

Paula MoralesInstituto de Química Médica, Consejo Superior de Investigaciones Científicas, Madrid, SpainCorrespondence[email protected]
View further author information
&
Nadine JagerovicInstituto de Química Médica, Consejo Superior de Investigaciones Científicas, Madrid, SpainView further author information
Pages 917-930 | Received 11 Feb 2020, Accepted 02 Apr 2020, Published online: 27 Apr 2020

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

AyoOluwa O. Aderibigbe, Pankaj Pandey & Robert J. Doerksen. (2022) Negative allosteric modulators of cannabinoid receptor 1: Ternary complexes including CB1, orthosteric CP55940 and allosteric ORG27569. Journal of Biomolecular Structure and Dynamics 40:13, pages 5729-5747.
Read now

Articles from other publishers (22)

Adi Gabarin, Ludmila Yarmolinsky, Arie Budovsky, Boris Khalfin & Shimon Ben-Shabat. (2023) Cannabis as a Source of Approved Drugs: A New Look at an Old Problem. Molecules 28:23, pages 7686.
Crossref
Jiayi Yuan, Bo Yang, Guanyu Hou, Xiang-Qun Xie & Zhiwei Feng. (2023) Targeting the endocannabinoid system: Structural determinants and molecular mechanism of allosteric modulation. Drug Discovery Today 28:7, pages 103615.
Crossref
Szabolcs Dvorácskó, Marilisa Pia Dimmito, Jessica Sebastiani, Giuseppe La Regina, Romano Silvestri, Stefano Pieretti, Azzurra Stefanucci, Csaba Tömböly & Adriano Mollica. (2023) Rimonabant-Based Compounds Bearing Hydrophobic Amino Acid Derivatives as Cannabinoid Receptor Subtype 1 Ligands. ACS Medicinal Chemistry Letters 14:4, pages 479-486.
Crossref
Rodrigo Pérez-Arancibia, Marisol Cisternas-Olmedo, Denisse Sepúlveda, Paulina Troncoso-Escudero & Rene L. Vidal. (2023) Small molecules to perform big roles: The search for Parkinson's and Huntington's disease therapeutics. Frontiers in Neuroscience 16.
Crossref
Luxman Srikantha & Nathan J. Gonik. 2023. Functional Illness of the Head and Neck. Functional Illness of the Head and Neck 251 261 .
Wahid Zada, Jonathan W. VanRyzin, Miguel Perez‐Pouchoulen, Samantha L. Baglot, Matthew N. Hill, Ghulam Abbas, Sarah M. Clark, Umer Rashid, Margaret M. McCarthy & Abdul Mannan. (2022) Fatty acid amide hydrolase inhibition and N‐arachidonoylethanolamine modulation by isoflavonoids: A novel target for upcoming antidepressants. Pharmacology Research & Perspectives 10:5.
Crossref
Janani Parameswaran, Leire Goicoechea, Laura Planas-Serra, Antoni Pastor, Montserrat Ruiz, Noel Y. Calingasan, Cristina Guilera, Ester Aso, Jordi Boada, Reinald Pamplona, Manuel Portero-Otín, Rafael de la Torre, Isidre Ferrer, Carlos Casasnovas, Aurora Pujol & Stéphane Fourcade. (2022) Activating cannabinoid receptor 2 preserves axonal health through GSK-3β/NRF2 axis in adrenoleukodystrophy. Acta Neuropathologica 144:2, pages 241-258.
Crossref
Ellen N. Hurley, Carolyn J. Ellaway, Alexandra M. Johnson, Linda Truong, Rebecca Gordon, Peter Galettis, Jennifer H. Martin & John A. Lawson. (2022) Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial. Epilepsia 63:7, pages 1736-1747.
Crossref
Ian Liddle, Michelle Glass, Joel D. A. Tyndall & Andrea J. Vernall. (2022) Covalent cannabinoid receptor ligands – structural insight and selectivity challenges. RSC Medicinal Chemistry 13:5, pages 497-510.
Crossref
Marek Zubrzycki, Maria Zubrzycka, Grzegorz Wysiadecki, Janusz Szemraj, Hanna Jerczynska & Mariusz Stasiolek. (2022) Effect of Fatty Acid Amide Hydrolase Inhibitor URB597 on Orofacial Pain Perception in Rats. International Journal of Molecular Sciences 23:9, pages 4665.
Crossref
Rosaria Greco, Chiara Demartini, Anna Maria Zanaboni, Miriam Francavilla, Roberto De Icco, Lara Ahmad & Cristina Tassorelli. (2022) The endocannabinoid system and related lipids as potential targets for the treatment of migraine‐related pain. Headache: The Journal of Head and Face Pain 62:3, pages 227-240.
Crossref
José‐Francisco Rocha, Ana Santos, Helena Gama, Paul Moser, Amílcar Falcão, Peter Pressman, A. Wallace Hayes & Patricio Soares‐da‐Silva. (2021) Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10‐2474: A Double‐Blind, Randomized, Placebo‐Controlled Study in Healthy Volunteers. Clinical Pharmacology & Therapeutics 111:2, pages 391-403.
Crossref
Özge Boyacıoğlu & Petek Korkusuz. 2023. Cell Biology and Translational Medicine, Volume 19. Cell Biology and Translational Medicine, Volume 19 145 169 .
Manuel A.A. De Prá, Renata Vardanega & Carla G. Loss. (2021) Lipid-based formulations to increase cannabidiol bioavailability: In vitro digestion tests, pre-clinical assessment and clinical trial. International Journal of Pharmaceutics 609, pages 121159.
Crossref
Stefano Salamone, Giovanni Appendino, Adil Khalili, Federica Pollastro, Eduardo Munoz & Juan D. Unciti-Broceta. (2021) Agathadiol, a labdane diterpenoid from juniper berries, is a positive allosteric modulator of CB1R. Fitoterapia, pages 105059.
Crossref
Jakub Jakowiecki, Renata Abel, Urszula Orzeł, Paweł Pasznik, Robert Preissner & Sławomir Filipek. (2021) Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling. Molecules 26:9, pages 2456.
Crossref
Jackson M. J. Oultram, Joseph L. Pegler, Timothy A. Bowser, Luke J. Ney, Andrew L. Eamens & Christopher P. L. Grof. (2021) Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC. Biomedicines 9:3, pages 234.
Crossref
Ana Lago-Fernandez, Sara Zarzo-Arias, Nadine Jagerovic & Paula Morales. (2021) Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System. International Journal of Molecular Sciences 22:3, pages 1001.
Crossref
Paula Morales & Patricia H. Reggio. 2021. Cannabinoids and Neuropsychiatric Disorders. Cannabinoids and Neuropsychiatric Disorders 47 65 .
Samuele Maramai & Margherita Brindisi. (2020) Targeting Endocannabinoid Metabolism: an Arrow with Multiple Tips Against Multiple Sclerosis. ChemMedChem 15:21, pages 1985-2003.
Crossref
Paula Morales, Marta Bruix & M. Angeles Jiménez. (2020) Structural Insights into β-arrestin/CB1 Receptor Interaction: NMR and CD Studies on Model Peptides. International Journal of Molecular Sciences 21:21, pages 8111.
Crossref
Filippo Basagni, Michela Rosini & Michael Decker. (2020) Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes. ChemMedChem 15:15, pages 1374-1389.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.